West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC reduced its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 2.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 39,817 shares of the medical instruments supplier’s stock after selling 1,158 shares during the quarter. Chevy Chase Trust Holdings LLC owned 0.05% of West Pharmaceutical Services worth $13,115,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the business. Fidelis Capital Partners LLC purchased a new position in shares of West Pharmaceutical Services during the 1st quarter worth approximately $27,000. Quarry LP lifted its stake in shares of West Pharmaceutical Services by 155.3% during the fourth quarter. Quarry LP now owns 97 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 59 shares during the period. Hazlett Burt & Watson Inc. purchased a new stake in West Pharmaceutical Services in the 1st quarter valued at about $40,000. Northwest Investment Counselors LLC acquired a new stake in West Pharmaceutical Services during the first quarter worth about $40,000. Finally, ORG Partners LLC raised its holdings in West Pharmaceutical Services by 820.0% in the first quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier’s stock valued at $55,000 after buying an additional 123 shares during the period. 93.90% of the stock is owned by hedge funds and other institutional investors.

West Pharmaceutical Services Trading Up 1.1 %

WST traded up $3.22 during trading on Wednesday, hitting $302.34. 47,703 shares of the company’s stock were exchanged, compared to its average volume of 566,456. The stock has a 50 day moving average price of $313.88 and a 200 day moving average price of $348.63. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 1 year low of $265.00 and a 1 year high of $415.73. The firm has a market cap of $21.93 billion, a P/E ratio of 39.46, a price-to-earnings-growth ratio of 10.68 and a beta of 1.00.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing analysts’ consensus estimates of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The company had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. During the same quarter in the prior year, the firm earned $2.11 EPS. The company’s revenue for the quarter was down 6.9% compared to the same quarter last year. As a group, analysts expect that West Pharmaceutical Services, Inc. will post 6.44 EPS for the current fiscal year.

Insider Buying and Selling

In other West Pharmaceutical Services news, SVP Silji Abraham sold 1,800 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $330.78, for a total value of $595,404.00. Following the completion of the sale, the senior vice president now owns 2,860 shares of the company’s stock, valued at $946,030.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.53% of the stock is currently owned by corporate insiders.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.